Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

Share Price is delayed by 15 minutes
Get Live Data
2,040.00    4.00 (0.20%)
Bid:
2,040.00
Ask:
2,042.00
Spread: 2.00 (0.098%)
Market Cap: £44.36b
STAN Live PriceLast checked at - London Stock Exchange

Intraday Standard Chartered Share Chart

Transaction in Own Shares

23 Mar 2023 18:00

RNS Number : 0773U
Standard Chartered PLC
23 March 2023
Β 

Β 

STANDARD CHARTERED PLC

Β 

23 March 2023

Β 

Transaction in own shares

Β 

Standard Chartered PLC ("SC") announces that today it purchased the following number of its ordinary shares of US$0.50 each from Goldman Sachs International, pursuant to the share buy-back programme previously detailed in the announcement of 17 February 2023 (the "Programme").

Β 

Ordinary shares:

Β 

Β 

Date of purchase:

23 March 2023

Β 

Β 

Aggregate number of ordinary shares purchased:

3,699,896

Β 

Β 

Lowest price paid per share:

630.80 pence

Β 

Β 

Highest price paid per share:

646.40 pence

Β 

Β 

Average price paid per share:

636.94 pence

Β 

Β 

Aggregated information of ordinary shares purchased today according to each trading venue:

Venue

Weighted average price paid per share (GB pence)

Aggregate number of shares purchased

Lowest price paid per share (GB pence)

Highest price paid per share (GB pence)

London Stock Exchange

636.85

1,934,000

630.80

646.40

CBOE BXE

637.11

1,126,603

631.20

642.40

CBOE CXE

636.90

639,293

631.00

642.40

Β 

Β 

SC intends to cancel the purchased shares.

Β 

Β 

Following the cancellation of the purchased shares, SC will have 2,837,755,548 ordinary shares in issue. Therefore, the total number of voting rights in SC will be 709,438,887.

Β 

Β 

Any share purchases pursuant to the Programme will be effected in accordance with certain pre-set parameters and limits, and in accordance with applicable law and regulation as described in more detail in SC's announcement of 17 February 2023.

Β 

Β 

In accordance with Article 5(1)(b) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), a full breakdown of the individual trades is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/0773U_1-2023-3-23.pdf

This announcement will also be available on SC's website at: https://www.sc.com/en/investors/stock-exchange-announcements/

Β 

Enquiries to:

Β 

Gregg J Powell, Head of Investor Relations +44 (0) 20 7885 5172

Β 

Shaun Gamble, Director, Group Media Relations: +44 (0) 20 7885 5934

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSFLFEDVFIVFIV
Date   Source Headline
8th Mar 20245:59 pmRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20246:02 pmRNSTransaction in Own Shares
6th Mar 202411:33 amRNSNotice of Redemption
5th Mar 20246:15 pmRNSTransaction in Own Shares
4th Mar 20246:04 pmRNSTransaction in Own Shares
1st Mar 20245:50 pmRNSTransaction in Own Shares
1st Mar 202412:00 pmRNSTotal Voting Rights
29th Feb 20246:15 pmRNSTransaction in Own Shares
29th Feb 20244:21 pmRNSPublication of Final Terms
29th Feb 20247:00 amRNSIssuance of U.S.$1bn Additional Tier 1 Securities
29th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20246:09 pmRNSTransaction in Own Shares
26th Feb 202410:03 amRNSShare Buy-Back
23rd Feb 20242:39 pmRNSFull Year 2023 Pillar 3 Disclosures
23rd Feb 202412:13 pmRNSPublication of Supplementary Prospectus
23rd Feb 20247:00 amRNSAnnual Report 2023
23rd Feb 20247:00 amRNSAdditional Financial Information - Part 2
23rd Feb 20247:00 amRNSAdditional Financial Information - Part 1
23rd Feb 20247:00 amRNSSCPLC Final Results 2023
16th Feb 202410:00 amRNSDirectorate Changes
8th Feb 202411:07 amRNSOverseas Regulatory Announcement
1st Feb 202410:26 amRNSTotal Voting Rights
26th Jan 202412:28 pmRNSDirector/PDMR Shareholding
17th Jan 202412:33 pmRNSPublication of Final Terms
5th Jan 202412:04 pmRNSPublication of Final Terms
2nd Jan 20243:33 pmRNSTotal Voting Rights
28th Dec 202311:22 amRNSPublication of Supplementary Prospectus
27th Dec 202312:36 pmRNSNotice of Redemption
21st Dec 20231:00 pmRNSDirectorate Change
1st Dec 202311:56 amRNSBlock listing Interim Review
1st Dec 202310:37 amRNSTotal Voting Rights
29th Nov 20231:42 pmRNSSCPLC Sustainability Investor Event
22nd Nov 20239:17 amRNSOverseas Regulatory Announcement
21st Nov 202310:28 amRNSOverseas Regulatory Announcement - Grant of Awards
9th Nov 202310:01 amRNSNotice of Redemption
8th Nov 20239:00 amRNSNotice of Redemption
6th Nov 20236:30 pmRNSTransaction in Own Shares
3rd Nov 20236:00 pmRNSTransaction in Own Shares
3rd Nov 202312:28 pmRNSPublication of Final Terms
3rd Nov 202312:05 pmRNS3Q 2023 Pillar 3 Disclosures
2nd Nov 20236:10 pmRNSTransaction in Own Shares
2nd Nov 20232:08 pmRNSSC completes sale of aviation leasing business
1st Nov 20235:53 pmRNSTransaction in Own Shares
1st Nov 202311:38 amRNSTotal Voting Rights
31st Oct 20236:00 pmRNSTransaction in Own Shares
30th Oct 20235:54 pmRNSTransaction in Own Shares
27th Oct 20236:20 pmRNSTransaction in Own Shares
26th Oct 20236:12 pmRNSTransaction in Own Shares
26th Oct 202312:20 pmRNSPublication of Supplementary Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.